For decades, pancreatic cancer has defied targeted therapies by rapidly evolving escape mechanisms. In a new study, Spanish researchers report that a carefully designed three-drug strategy shut down those escape routes entirely in laboratory models, producing complete and durable tumor regression.

If telomeres determine cellular lifespan, could reprogramming them allow cells, and ultimately humans, to live indefinitely?